VYVGART
VYVGART (EfgartigVyvgart (Efgartigimod) IV Infusion | Myasthenia Gravis Therapyimod Alfa-Fcab) is an FDA-approved monoclonal antibody infusion therapy indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. Each single-dose, preservative-free 1×20 mL vial contains Efgartigimod Alfa-Fcab, formulated for intravenous administration under professional supervision.
Efgartigimod works by reducing pathogenic IgG autoantibodies that attack the neuromuscular junction, helping to improve muscle strength, reduce fatigue, and enhance overall patient functionality. This targeted therapy provides an important treatment option for patients with moderate to severe generalized myasthenia gravis.
InfusionMed USA, based in Carrollton, Texas, supplies VYVGART and other specialty neurology infusion therapies to hospitals, clinics, and specialty infusion centers across Dallas, McKinney, Frisco, Plano, Lewisville, The Colony, and surrounding North Texas areas. We ensure cold-chain integrity, proper handling, and timely delivery for licensed healthcare providers.
For professional use only.
Download Form